Impact of RANTES, MCP-1 and IL-8 in mast cells

Journal of Biological Regulators and Homeostatic Agents

Volumn 24, Issue 1, 2010, Pages 1-6

  Castellani, Maria Luisa ^a   De Lutiis, M A ^a   Toniato, E ^a   Conti, F ^b   Felaco, P ^a   Fulcheri, M ^a   Theoharides, T C ^c   Caraffa, A ^d   Antinolfi, P ^d   Conti, P ^a   Cuccurullo, C ^a   Ciampoli, C ^a   Felaco, M ^a   Orso, C ^a   Salini, V ^a   Cerulli, G ^d   Kempuraj, D ^c   Tete S ^a   Shaik, B ^e  

^a UNIVERSITY OF CHIETI   (Italy)

^b Vasto Hospital   (Italy)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PERUGIA   (Italy)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IL 8; Mast cells; MCP 1; RANTES

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; AUTACOID; SEROTONIN;

ARTICLE; CELL ACTIVATION; CELL FUNCTION; HUMAN; INFLAMMATION; MAST CELL; MUSCLE TISSUE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD; ANIMAL; EDITORIAL; HISTAMINE RELEASE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CHEMOKINE CCL2; CHEMOKINE CCL5; HISTAMINE RELEASE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-8; MAST CELLS; SEROTONIN; SIGNAL TRANSDUCTION;

EID: 77953726000     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Levy JA. The unexpected pleiotropic activities of RANTES. J Immunol 2009; 182: 3945-6.
2. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nature Reviews: Immunology 2005; 5: 953-62.
3. Conti P, Boucher W, Letourneau R, et al. Monocyte chemotactic protein-1 provokes mast cell aggregation and [3H]5HT release. Immunology 1995; 86:434-40.
4. Conti P, Reale M, Barbacane R.C, Letourneau R, Theoharides TC. Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: lack of effects in genetically mast cell-deficient W/WV mice. FASEB J 1998; 12:1693-700. (Pubitemid 28553664)
5. Levy JA. The unexpected pleiotropic activities of RANTES. J Immunol 2009; 182:3945-6.
6. Oppenheim JJ, Zacharie COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "Intercrine" cytokine family. Annu Rev Immunol 1991; 9:617:23.
7. Gibbs BF. Differential modulation of IgE-dependent activation of human basophils by ambroxol and related secretolytic analogues. Int J Immunopathol Pharmacol 2009; 22:919-27.
8. Yin Y, Yan Y, Jiang X, Mai J, Chen NC, Wang H, Yang X-F. Inflammasomes are differentially expressed in cardiovascular and other tissues. Int J Immunopathol Pharmacol 2009; 22:311-322.
9. Castellani ML, Vecchiet J, Salini V, et al. Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance p in LAD2 human mast cells Tranl Res 2009; 154:27-33.
10. Katsanos GS, Anogeianaki A, Orso C, Tetè S, Salini V, Antinolfi PL, Sabatino G. Mast cells and chemokines. J Biol Regul Homeost Agents 2008; 22: 145-51.
11. Conti P, Pang X, Boucher W, Letourneau R, Reale M, Barbacane RC, Thibault J, Theoharides TC. Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 1997; 89: 4120-7.
12. Conti P, Reale M, Barbacane RC, Felaco M, Grilli A, Theoharides TC. Mast cell recruitment after subcutaneous injection of RANTES in the sole of the rat paw. Br J Haematol 1998; 103:798-803. (Pubitemid 28545320)
13. Conti P, Pang X, Boucher W, Letourneau R, Reale M, Barbacane RC, Thibault J, Theoharides TC. RANTES is a pro-inflammatory chemokine and chemoattracts basophil cells to extravascular sites. J Pathol 1997; 183:352-8.
14. Conti P, Reale M, Barbacane RC, et al. Massive infiltration of basophilic cells in inflamed tissue after injection of RANTES. Immunol Lett 1997; 58:101-6.
15. Stelekati E, Bahri R, D'Orlando O, et al. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity 2009; 31:665-76.
16. Caldarola G, De Simone C, Carbone A, Tulli A, Amerio P, Feliciani C. TNFα and its receptors in psoriatic skin, before and after treatment with Etanercept. Int J Immunopathol Pharmacol 2009; 22:961-6.
17. Theoharides TC, Makris M, Kalogeromitros D. Allergic inflammation and adipocytokines. Int J Immunopathol Pharmacol 2008; 21:1-4.
18. Ciprandi G, Fenoglio D, De Amici M, Marseglia G, Murdaca G, Di Gioacchino M. Serum IL-1 after one course of sublingual immunotherapy in allergic rhinitis to birch. Eur J Inflamm 2009; 7:49-54.
19. Di Gioacchino M, Perrone A, Petrarca C, et al. Early cytokine modulation after the rapid induction phase of sublingual immunotherapy with mite monomeric allergoids. Int J Immunopathol Pharmacol 2008; 21: 969-76
20. Indinnimeo L, Bertuola F, Cutrera R, et al. Clinical evaluation and treatment of acute asthma exacerbations in children. Int J Immunopathol Pharmacol 2009; 22:867-78.
21. Di Bonito P, Grasso F, Mangino G, et al. Immunomodulatory activity of a plant extract containing human papillomavirus 16-E7 protein in human monocyte-derived dendritic cells. Int J Immunopathol Pharmacol 2009; 22:967-78.
22. Di Bonito P, Grasso F, Mangino G, et al. Immunomodulatory activity of a plant extract containing human papillomavirus 16-E7 protein in human monocyte-derived dendritic cells. Int J Immunopathol Pharmacol 2009; 22:967-78.
23. Theoharides TC, Conti P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 2004; 25: 235-41.
24. Castellani ML, Felaco P, Pandolfi F, et al. Inflammatory compounds: neuropeptide substance P and cytokines. Eur J Inflamm 2009; 7:63-70.
25. Karapanou V, Kempuraj D, Theoharides TC. Oral neuroimmune network and mast cells. Eur J Inflamm 2009; 7:1-8.
26. Ciprandi G, Cadario G, Di Gioacchino M, et al. Intermittent and persistent allergic rhinitis and association with asthma in children. Eur J Inflamm 2008; 6:123-8.
27. Castellani ML, Kempuraj D, Frydas S, Theoharides TC, Simeonidou I, Conti P, Vecchiet J. Inhibitory effect of quercetin on tryptase and MCP-1 chemokine release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Neuroimmunomodulation 2006; 13:179-86. (Pubitemid 46180180)
28. Castellani ML, Bhattacharya K, Tagen M, et al. Anti-chemokine therapy for inflammatory diseases. Int J Immunopathol Pharmacol 2007; 20:447-53.
29. Katsanos GS, Anogeianaki A, Orso C, Tetè S, Salini V, Antinolfi PL, Sabatino G. Substance P: an inflammatory peptide. Eur J Inflmm 2008; 6:59-64.
30. Frydas S, Papaioannou N, Reale M, Barbacane RC, Conti P. MCP-1 and MIP-2 response in Trichinella spiralis-infected mice treated with 4-deoxypyridoxine (4-DPD). Immunol Lett 2002; 83:31-7.
31. Chiba Y, Sato S, Misawa M. GGTI-2133, an inhibitor of geranylgeranyltransferase, inhibits infiltration of inflammatory cells into airways in mouse experimental asthma. Int J Immunopathol Pharmacol 2009; 22:929-35.
32. Di Paola R, Crisafulli C, Mazzon E, Genovese T, Paterniti I, Bramanti P, Cuzzocrea S. Effect of PD98059, a selective MAPK3/MAPK1 inhibitor, on acute lung injury in mice. Int J Immunopathol Pharmacol 2009; 22:937-50.
33. Amedei A, Della Bella C, Niccolai E, Stanflin N, Benagiano M, Duranti R, Del Prete G, Murphy TF, D'Elios MM. Moraxella catarrhalis-specific TH1 cells in BAL fluids of chronic obstructive pulmonary disease patients. Int J Immunopathol Pharmacol 2009; 22:979-90.
34. Di Lorenzo G, Mansueto P, Pacor ML, et al. Clinical importance of eosinophil count in nasal fluid in patients with allergic and non-allergic rhinitis. Int J Immunopathol Pharmacol 2009; 22:1077-87.
35. Lee H, Han AR, Kim Y, Choi SH, Ko E, Lee NY, Jeong JH, Kim SH, Bae H. A new compound, 1H,8H-pyrano[3,4-c]pyran-1,8-dione, suppresses airway epithelial cell inflammatory responses in a murine model of asthma. Int J Immunopathol Pharmacol 2009; 22:591-603.
36. Conti P, Kempuraj D, Kandere K, et al. Interleukin-16 network in inflammation and allergy. Allergy Asthma Proc 2002; 23:103-8.
37. Malerba M, Mennuni L, Piepoli T, Caselli G, Makovec F, Rovati LC, D'amato M, Ferrari F. Andolast acts at different cellular levels to inhibit immunoglobulin E synthesis. Int J Immunopathol Pharmacol 2009; 22:85-94.
38. Del Prete G, Santi L, Andrianaivoarimanana V, Amedei A, Domarle O, D'Elios MM, Arntzen CJ, Rahalison L, Mason HS. Plant-derived recombinant F1, V, and F1-V fusion antigens of Yersinia pestis activate human cells of the innate and adaptive immune system. Int J Immunopathol Pharmacol 2009; 22:133-43.
39. Fietta AM, Morosini M, Passadore I, Cascina A, Draghi P, Dore R, Rossi S, Pozzi E, Meloni F. Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer. Hum Immunol 2009; 70:477-86.
40. Castellani ML, Conti P, Felaco M, Vecchiet J, Ciampoli C, Cerulli G, Boscolo P, Theoharides TC. Substance P upregulates LTB4 in rat adherent macrophages from granuloma induced by KMnO4. Neurotox Res 2009; 15:49-56.
41. Castellani ML, Ciampoli C, Felaco M, et al. Neuropeptide substance P induces mRNA expression and secretion of CXCL8 chemokine, and HDC in human umbilical cord blood mast cells. Clin Invest Med 2008; 31:E362-72.